27.12.2018

Legislative Proposal to Ease Establishment and Fundraising of Domestic Private Equity Funds — Tax Treatment of foreign Funds of Funds to be Clarified

Background

On 13 December 2018, the Finnish Government published a legislative proposal aimed at eliminating problems in tax legislation relating to the establishment of private equity funds in the form of limited partnerships.

The taxation of investors in private equity funds operating in a form of a Finnish limited partnership has, in certain respects, been based on established case law and tax practice. The taxation of foreign investors was originally eased through a special provision enacted in 2005 (Income Tax Act section 9(5)). When the special provision applies, an investor, having limited tax liability in Finland and being a limited partner in Finnish PE fund operating in a form of a limited partnership, is taxed for its share of the income of the fund only to the extent the income would be taxable if received directly by that investor.

However, the case law relating to the special provision deemed that the special provision did not apply to partners in foreign, tax-transparent limited partnership funds, i.e. foreign funds of funds. This watered down key features of financial purpose of the provision.

Legislative Amendment

According to the new government proposal, the special provision could in future also be applied to entities with limited tax liability in Finland investing in limited partnership PE funds through one or more domestic or foreign partnerships. This requires, among other things, that the ultimate investor is subject to a tax treaty between Finland and the investor’s home state and that a partnership investing in a Finnish limited partnership is registered in a jurisdiction with which Finland has an agreement on the exchange of tax information in place.

The special provision also requires that an investor in a Finnish limited partnership is a domestic or foreign partnership—for example, the special provision does not apply to foreign contractual funds. The special provision applies to alternative investment funds in accordance with the Act on Alternative Investment Funds regardless of whether the alternative investment fund manager is licenced or obligated to register.

Impact

The purpose of the legislative amendment is to make it easier for domestic PE funds to raise foreign capital. The achievement of this goal is being sought through an expansion of the existing special provision. Though the special provision still has the limitations described above, these limitations can be considered materially justified.

The concrete practical impact of the amendment remains to be seen. In any case, it removes one artificial and unnecessary obstacle to foreign investments in domestic PE funds.

This amendment has been on the wish list of the investment field for quite some time, and it is believed that is will increase foreign investment in domestic PE funds.

Latest references

We are proud to have provided legal assistance to PwC in the successful public tendering process for the comprehensive renewal of Kela’s benefits processing systems. Kela is the Social Insurance Institution of Finland, and this project is a significant cornerstone in modernising Finland’s social security infrastructure. PwC was selected as Kela’s strategic partner to implement a comprehensive overhaul of the benefits processing systems, digital services, customer relationship management, and information exchange platforms. The project aims to meet the demands of the future digital environment and enhance customer experience through the adoption of Salesforce technology. The new systems are expected to simplify benefit processes, enhance user experience for both customers, employees and other stakeholders, and ensure adaptability to future legislative changes. Castrén & Snellman provided strategic legal support to PwC throughout its successful bidding process, which was carried out through a competitive negotiated procedure. We extend our warmest congratulations to PwC for their successful bid and look forward to seeing the positive impact of this project on Finland’s social security system.
Case published 24.4.2025
We advised Milexia Group, a portfolio company of the French PE sponsor Crédit Mutuel Equity, on its acquisition of the activities of Alpha Positron Oy, a Finnish distributor specializing in GPS/GNSS, time and frequency solutions for the electronics industry, process automation, corporate IT, defense, and other demanding markets. Milexia Group is one of the world’s leading European suppliers for high-quality electronic components, systems and scientific instruments technology. It has offices, warehouses and technical centres in France, Italy, Spain, the United Kingdom, Germany, Nordics and Hong Kong. The acquisition aligns with Milexia’s strategy to expand its presence in the Nordic region and enhance its portfolio of communication solutions.
Case published 24.4.2025
We are acting as legal advisor to Piippo Plc in the sale of their bale netwrap and baler twine machines, related assets, and trademarks used in Piippo’s business to Portuguese Cotesi S.A. The sale of assets will be carried out in two phases and the final completion of the transaction is expected to occur during the first quarter of 2026. Piippo Oyj’s core business is baling nets and twine and it is one of the leading suppliers in the industry globally. The company’s global distribution network covers more than 40 countries. The company’s shares are listed on the First North Growth Market Finland operated by Nasdaq Helsinki Oy. Founded in 1967, Cotesi is one of the world’s leading producers of synthetic and natural twines, nets and ropes, with operations in Europe, North America and South America and its main production plant in Vila Nova de Gaia, Portugal.
Case published 17.4.2025
We acted as Finnish legal adviser to KKR in connection with its acquisition of the entire share capital of Karo Healthcare from EQT. The transaction follows Karo’s significant strategic transformation from a Nordic specialty pharma business into a leading pan-European consumer healthcare platform, with an attractive product portfolio spanning core categories such as Skin Health, Foot Health, and Intimate Health, as well as Digestive Health and Vitamins, Minerals & Supplements. KKR & Co. Inc. (NYSE: KKR), is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds.  Completion of the transaction is subject to customary conditions and regulatory approvals. The transaction is expected to close in the coming months.
Case published 17.4.2025